LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services... Show more
Industry ServicestotheHealthIndustry
A.I.dvisor indicates that over the last year, LFMD has been loosely correlated with PAYS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LFMD jumps, then PAYS could also see price increases.
| Ticker / NAME | Correlation To LFMD | 1D Price Change % | ||
|---|---|---|---|---|
| LFMD | 100% | +0.66% | ||
| PAYS - LFMD | 41% Loosely correlated | -2.47% | ||
| AFRM - LFMD | 39% Loosely correlated | +5.07% | ||
| DAVE - LFMD | 38% Loosely correlated | -2.13% | ||
| VERX - LFMD | 37% Loosely correlated | -0.08% | ||
| PAY - LFMD | 37% Loosely correlated | +0.28% | ||
More | ||||
| Ticker / NAME | Correlation To LFMD | 1D Price Change % |
|---|---|---|
| LFMD | 100% | +0.66% |
| Services to the Health Industry industry (42 stocks) | 20% Poorly correlated | +0.43% |
| Health Services industry (242 stocks) | -1% Poorly correlated | +0.38% |
The RSI Oscillator for LFMD moved out of oversold territory on September 10, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 28 of the 32 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for LFMD just turned positive on August 19, 2026. Looking at past instances where LFMD's MACD turned positive, the stock continued to rise in 37 of 43 cases over the following month. The odds of a continued upward trend are 86%.
Following a +3.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where LFMD advanced for three days, in 249 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The 50-day moving average for LFMD moved below the 200-day moving average on September 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for LFMD entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.450) is normal, around the industry mean (7.171). LFMD has a moderately low P/E Ratio (0.000) as compared to the industry average of (44.460). LFMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.499). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.749) is also within normal values, averaging (5.983).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. LFMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.